1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Peerless - worst distributor

Discussion in 'Arthrex' started by anonymous, Jul 30, 2015 at 12:17 PM.

  1. anonymous

    anonymous Guest

    Preach on Kirk....preach on!!!!!
     
  2. anonymous

    anonymous Guest

    PB, docs come and go. Cases ebb and flow. Monthly Arthrex numbers are set and met, but Christmas comes but once a year. Merry Christmas to the best boss this side of the Cuba.
     
  3. anonymous

    anonymous Guest

    These last few posts are really weird. Sound like you all just get in a conference room and have a circle jerk.
     
  4. anonymous

    anonymous Guest

    Dear PB, I look forward to another fantastic year working for you. You have provided a terrific example, a role model, of how a person should work, behave and be a blessing to Arthrex, to our patients, to family and to society. Happy New Year 2019 to the best boss ever.
     
  5. anonymous

    anonymous Guest

    Come back we miss you.
     
  6. anonymous

    anonymous Guest

    Why is there so much turnover with this company?
     
  7. anonymous

    anonymous Guest

    Why is this pathetic thread still going? That’s the question!
     
  8. anonymous

    anonymous Guest

    Gotham and Novus most unethical
     
  9. anonymous

    anonymous Guest

    I miss you guys
     
  10. anonymous

    anonymous Guest

    How are the Peerless numbers stacking up. Good year, bad year, or awful year?